Unveiling the ECMO Devices Market: Key Trends and Developments
Unveiling the ECMO Devices Market: Key Trends and Developments
Blog Article
Unveiling the ECMO Devices Market: Key Trends and Developments
Global ECMO Devices Market Poised for Steady Growth
The global extracorporeal membrane oxygenation (ECMO) devices market is anticipated to grow at a CAGR of 4.1% from 2024 to 2030. The rising incidence of chronic respiratory and cardiac conditions, advancements in ECMO technology enhancing patient outcomes, and the increasing adoption of ECMO machines are key factors driving market expansion. Additionally, the launch of innovative ECMO solutions, the growing burden of lung and heart diseases, and an increase in product approvals and regulatory support contribute to market growth.
Recent Developments in the ECMO Market
- August 2022: AirECMO, Inc., a division of Keystone Perfusion Services, partnered with REVA, a leading air ambulance provider, to improve global ECMO transport services.
- July 2022: Inspira™ Technologies introduced the Liby System, an advanced ECMO-based life support solution for patients with severe heart and lung failure.
- April 2020: The U.S. FDA issued guidelines to facilitate the availability of ECMO devices in response to the COVID-19 crisis.
- April 2020: Abiomed acquired Breethe, a company specializing in innovative ECMO systems, expanding its portfolio to serve patients with respiratory failure and cardiogenic shock due to ARDS, H1N1, SARS, or COVID-19.
Market Dynamics Driving ECMO Adoption
A key driver of ECMO market expansion is the growing prevalence of cardiovascular and respiratory diseases. ECMO provides long-term circulatory and gas exchange support for critically ill patients.
- Ischemic heart disease (IHD), also known as coronary artery disease (CAD), is one of the leading causes of death worldwide. A 2020 study estimated that 126 million people (1.72% of the global population) suffer from the disease annually. Patients undergoing cardiovascular surgeries often require ECMO support, further driving market demand.
- The British Heart Foundation (2023) reported that 620 million people globally are affected by heart and circulatory diseases.
- According to WHO (2021), cardiovascular diseases accounted for 17.9 million deaths, 31% of total global deaths, with projections reaching 23.6 million by 2030.
ECMO Devices Market Segmentation
The ECMO devices market is categorized based on machine modality, patient type, application, and region:
- By Machine Modality: Veno-Arterial, Veno-Venous, and Arterio-Venous
- By Patient Type: Pediatric and Adult
- By Application: Respiratory, Cardiac, and Others
- By Region: North America, Europe, Asia-Pacific, and the Rest of the World
The respiratory segment is expected to hold a significant market share, driven by high respiratory disease prevalence. Asthma, a leading non-communicable disease, affected 262 million people globally in 2019, leading to 250,000 deaths annually (WHO).
ECMO's role in severe COVID-19 cases has also been recognized. Data from the Extracorporeal Life Support Organization (ELSO) revealed that ECMO improved survival rates in critically ill COVID-19 patients when conventional ventilation failed, with a 55% survival rate for patients placed on ECMO.
North America Dominates the ECMO Market
North America is expected to lead the ECMO devices market, driven by:
- High prevalence of cardiovascular and respiratory diseases
- Aging population
- Technological innovations
The COVID-19 pandemic accelerated demand for ECMO systems, particularly compact cardiopulmonary bypass devices. In October 2020, Abiomed secured FDA 510(k) clearance for its Breethe OXY-1 system, further propelling ECMO market growth in the United States.
According to the CDC:
- Over 795,000 strokes occur annually in the U.S.
- Around 200,000 coronary artery bypass graft (CABG) surgeries are performed each year.
To address this increasing demand, the FDA granted clearance to Abiomed’s Breethe OXY-1 System in October 2020.
Key Players in the ECMO Market
The ECMO market is highly competitive, with several key companies driving innovation:
- Getinge Group
- Medtronic
- LivaNova PLC
- XENIOS AG
- Terumo Corporation
- MicroPort Scientific Corporation
- NIPRO Corporation
- OriGen Biomedical, Inc.
- EUROSETS S.r.l.
- ALung Technologies, Inc.
- Medos Medizintechnik AG
- Abiomed
- Novalung
- Sorin
- Thoratec Corporation
- MAQUET Holding B.V. & Co. KG
- Tianjin Medical
- Shandong WEGO New Life Medical Devices Co., Ltd.
Future Outlook
The ECMO devices market is set for steady expansion, driven by the increasing incidence of cardiovascular and respiratory diseases, technological innovations, and rising ECMO adoption globally. North America remains at the forefront, supported by a robust healthcare infrastructure and frequent product approvals. As new players enter the market and existing companies continue to innovate, the ECMO industry is expected to experience significant growth in the coming years.
Related Reports by DelveInsight:
Adalimumab Biosimilar Market | Arbovirus Infection Market | Artificial Pancreas Device System Market | Dental Equipment Market | Gluten Sensitivity Market | Hypothyroidism Market | Inflammatory Bowel Disease Market | Mayus Kinase Jak Inhibitors Market | Mild Dry Eye Market | Mucopolysaccharidosis Market | Oncolytic Virus Cancer Therapy Market | Pyoderma Gangrenosum Market | Transdermal Drug Delivery Devices Market | Intrathecal Pumps Market | Hedgehog Pathway Inhibitors Market | Yellow Fever Market | Laryngeal Cancer Market | Female Infertility Market | Gender Dysphoria Market | Chronic Brain Damage Market | Spain Healthcare Outlook Market | Malignant Fibrous Histiocytoma Market | Asthma Diagnostic Devices Market | Chronic Obstructive Pulmonary Disease Treatment Devices Market | Airway Management Devices Market | Cough Assist Devices Market | Pulse Oximeters Market | Hemodialysis Catheter Devices Market | Chronic Spontaneous Urticaria Market | Gender Dysphoria Market | Germany Healthcare Outlook | Biopsy Devices Pipeline Insight | Bacterial Conjunctivitis Market | Infliximab Biosimilar Insight | Eosinophilic Asthma Market | Cushing Syndrome Market | Functional Dyspepsia Market | Peripherally Inserted Central Catheters (PICC) Devices Market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Info:
Kritika Rehani
krehani@delveinsight.com
[email protected]
www.delveinsight.com
+14699457679
Report this page